‘Positive’ trial for Pfizer-BioNTech COVID-flu jab

by

Germany’s BioNTech and US pharmaceutical giant Pfizer on Thursday announced “positive” results from initial trials of their combined mRNA vaccine against COVID-19 and influenza.

Leave A Comment

Your email address will not be published. Required fields are marked *